Global drugmakers eye more China biotech deals after record year
ORIGINAL SOURCE →via Nikkei Markets
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · CN
- [HEALTH] Who writes the pandemic? State power, individual subjectivity, and the history of the present in China's COVID-19 respon
- [CONFLICT] China April PMI: Factory growth beats expectations at 50.3; services slump to 49.4
- [HEALTH] Tibetan herder goes from internet darling to tourism ambassador, now romantic film actor
- [FINANCE] Analysis-White House quiet as China ramps up trade leverage before Trump-Xi summit
- [FINANCE] Euroseas in fresh China newbuild move
- [CONFLICT] China’s ‘Big Three’ swing to first-quarter profits